Aytu BioPharma reported a decrease in net revenue for Q2 2025, reflecting challenges in its ADHD portfolio. Despite this, the company posted a net income of $800,000, translating to $0.13 per share.

Amid global alarm, top administration officials sought to soften elements of President Trump’s proposal to force Palestinians out of the territory and take it over. Experts said the plan would violate ...

Japan's Panasonic Holdings said on Thursday the third-quarter operating profit of its energy unit, which supplies batteries ...

The Indian Coast Guard (ICG) is set to commemorate its 49th Raising Day on Feb 1, 2025, marking nearly five decades of dedicated service to the nation. From its humble beginnings in 1977, with just ...

to ensure all children achieve foundational learning. By endorsing the CtA, countries and organizations commit to taking urgent and decisive action to reduce by half the global share of children ...

Foulkes revealed that Navico Group experienced sequential earnings growth in Q4, supported by strong aftermarket sales and operational efficiencies. Brunswick provided 2025 guidance for net sales ...

WILLIAMSVILLE, N.Y. (WKBW) — The National Assessment of Educational Progress released its 2024 scores this week and the Nation's Report Card shows yet another drop in reading scores across the ...

Mumbai: Aga Khan Agency for Habitat (AKAH) and Mira Bhayandar Municipal Corporation (MBMC) jointly launched a Climate Action Plan to achieve net ... Mira Bhayandar that target a minimum 20% ...

Total sales of $124.30 billion for the fiscal first quarter ended Dec. 28 inched past Wall Street's target of $124.12 billion, according to LSEG, while earnings per share of $2.40 comfortably beat ...

MIDLAND, Mich., Jan. 30, 2025 -- Dow Inc. (NYSE: DOW) today announced targeted actions to deliver $1 billion in cost savings.